Presentation Information
[27-61-am-22S]A pyridinium-type fullerene derivative reduced the viability of primary effusion lymphoma cells
○Nonoka Suzuki1, Jun Kawase1, Misa Takagi1, Ayano Kadota1, Misato Moriguchi 1, Tadashi Watanabe1, Shigeo Nakamura 2, Takumi Yasuno3, Tomoyuki Ohe3, Tadahiko Mashino3, Masahiro Fujimuro1 (1. Kyoto Pharm. Univ., 2. Nippon Medical School., 3. Keio Univ.)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.